Verified

Reagents:

Recombumin® Elite

Unlock the Power of Recombumin® Elite for Your Therapeutic Innovations

Sartorius Stedim Biotech GmbH

Recombumin® Elite recombinant human albumin is produced in a proprietary yeast strain to ICHQ7 cGMP standards. Recombumin® Elite has multiple applications in cell therapies, gene therapies, viral-based therapies, vaccines, medical devices and diagnostics.

Recombumin® Elite recombinant human albumin is a multifunctional excipient, ancillary and raw material, manufactured to ICHQ7 cGMP standards. Recombumin® Elite has multiple applications in cell therapies, gene therapies, viral-based therapies, vaccines, medical devices, and diagnostics.

Key Features

  • Security of supply | Recombumin® can be shipped worldwide*.
  • Batch-to-batch consistency | Reducing process variation, which affects HSA (human blood product) users.
  • Regulatory support for the product | The Recombumin® portfolio is supported by a comprehensive regulatory package and filings in key markets globally.
  • Market experience | Dosed well over 200 million times in a paediatric vaccine product and used in licensed and marketed therapeutics & medical devices; be confident in the safety and performance of Recombumin®.
  • Recombinant | 100% animal and human origin free and chemically definedICHQ7 cGMP manufacturing standard | The Recombumin® portfolio delivers unsurpassed quality and has never been the subject of a product recall.
  • Drug Master Files | Extensive regulatory packages and experience supports products from the research lab to the clinic.

Recombumin® Elite Supports in the Manufacture of

  • Cell therapies
  • Gene therapies
  • Protein based therapies
  • Viral based therapies
  • Vaccines
  • Medical devices
  • Diagnostics

Example Workflow Applications

  • Media and buffer preparation
  • Cell selection
  • Transduction
  • Expansion
  • Differentiation
  • Harvest
  • Cryopreservation
  • Excipient
  • Biological

*Excluding Russia

Product classification Recombumin® Elite

Request information about Recombumin® Elite now

Reagents: Recombumin® Elite

Unlock the Power of Recombumin® Elite for Your Therapeutic Innovations

Sartorius Stedim Biotech GmbH
All about Sartorius

Find Recombumin® Elite and related products in the theme worlds

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.